Circulating MicroRNAs as Specific Biomarkers in Atrial Fibrillation: A Meta-Analysis

Antônio da Silva Menezes Junior1,2, Lara Cristina Ferreira1, Laura Júlia Valentim Barbosa1

  • 1Internal Medicine Department, Cardiology and Genetic Section, Pontifical Catholic University of Goiás, Goiânia 74175-120, GO, Brazil.

Non-Coding RNA
|February 24, 2023
PubMed

Insights

Circulating microRNAs (miRNAs) show significant associations with atrial fibrillation (AF), indicating their potential as diagnostic and prognostic biomarkers. This meta-analysis confirms miRNAs

Area of Science:

  • Biochemistry and Molecular Biology
  • Cardiology
  • Genetics

Background:

  • Atrial fibrillation (AF) is a prevalent arrhythmia with complex pathogenesis.
  • MicroRNAs (miRNAs) are implicated in AF development, but standardized biomarker protocols are lacking.
  • Optimizing miRNA quantification is crucial for clinical application in AF diagnosis and prognosis.

Purpose of the Study:

  • To evaluate the clinical utility of circulating miRNAs as biomarkers for atrial fibrillation (AF) prognosis and diagnosis.
  • To analyze the association between circulating miRNAs and AF through a systematic literature review and meta-analysis.

Main Methods:

  • Conducted literature searches on PubMed, Cochrane Library, and EMBASE for observational studies on circulating miRNAs and AF.
  • Selected studies using blood plasma samples and RT-qPCR for miRNA detection, excluding atrial tissue samples.
  • Performed a meta-analysis on 6 selected studies, extracting data on specific miRNAs and their association with AF.

Main Results:

  • Identified significant associations between AF and specific miRNAs: miR-4798, miRNA-133a, miRNA-150, miRNA-21, hsa-miRNA4443, and miR-20a-5p.
  • The overall meta-analysis showed a combined odds ratio (OR) of 2.51 (95% CI 1.99-3.16) for the association between circulating miRNAs and AF.
  • Circulating miRNAs demonstrated stable expression post-sample collection, supporting their biomarker potential.

Conclusions:

  • Circulating miRNAs are promising biomarkers for the diagnosis and prognosis of atrial fibrillation.
  • Specific miRNAs, including miR-4798, miRNA-133a, miRNA-150, miRNA-21, hsa-miRNA4443, and miR-20a-5p, are significantly associated with AF.
  • Further optimization of miRNA quantification protocols is needed for widespread clinical adoption.

Related Concept Videos